Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Kotaro Asanuma"'
Publikováno v:
Parkinsonism & Related Disorders. 44:154-156
Autor:
Hiroyuki Nodera, Yoshimitsu Shimatani, Kotaro Asanuma, Atsuko Nodera, Takahiro Okita, Yoshiko Shibuta, Yuishin Izumi, Ryuji Kaji, Kenta Sato
Publikováno v:
Journal of the Neurological Sciences. 302:29-32
Recently, new electrophysiological ALS criteria incorporating fasciculation potentials (FPs) as evidence for lower motor neuron signs (Awaji Criteria (AC)) was proposed to provide earlier detection of early-stage ALS than revised El Escorial electrop
Autor:
Hiroyuki Nodera, Yuishin Izumi, Yoshimitsu Shimatani, Kotaro Asanuma, Atsuko Nodera, Ryuji Kaji, Yoshiko Shibuta
Publikováno v:
Rinsho Shinkeigaku. 51:1114-1117
Amyotrophic lateral sclerosis (ALS) is characterized by increased excitability of motor neurons and early involvement of large motor fibers that have low electrical thresholds. Despite the advent of new techniques of threshold tracking, exploration o
Autor:
Yuishin Izumi, Junichiro Satomi, Hiromu Nishitani, Ryuuji Kaji, Kotaro Asanuma, Masaaki Uno, Masafumi Harada, Naomi Morita, Shinji Nagahiro
Publikováno v:
Cerebrovascular Diseases. 29:571-575
Background: The purpose of this study was to determine the incidence and clinical correlation of intracranial hemorrhages (ICHs) detected by 3-tesla gradient echo T2*-weighted images after intravenous recombinant tissue plasminogen activator (rt-PA)
Autor:
Ryo Urushihara, Hideki Shimazu, Haruo Uguisu, Nagako Murase, Kotaro Asanuma, Ryuji Kaji, Yuki Hosono
Publikováno v:
The Journal of Medical Investigation. 57:109-113
In order to investigate the transcallosal effects of repetitive transcranial magnetic stimulation (rTMS), we studied median somatosensory evoked potentials (SEPs) before and after applying monophasic very low-frequency (0.2 Hz) subthreshold rTMS over
Autor:
Ryuji Kaji, Yuki Hosono, Yamato Kunikane, Masafumi Harada, Naomi Morita, Ryo Urushihara, Nagako Murase, Haruo Uguisu, Kotaro Asanuma, Hideki Shimazu
Publikováno v:
Clinical Neurophysiology. 119:2538-2545
Objective To optimize the clinical uses of repetitive transcranial magnetic stimulation (rTMS), we compared the effects of rTMS on somatosensory-evoked potentials (SEPs) and regional cerebral blood flow (rCBF) using different phases (monophasic vs. b
Autor:
Kotaro Asanuma, Vijay Dhawan, Yilong Ma, Chengke Tang, Shigeki Hirano, Andrew Feigin, Maren Carbon, David Eidelberg
Publikováno v:
The Journal of Neuroscience. 28:4201-4209
We compared the metabolic and neurovascular effects of levodopa (LD) therapy for Parkinson's disease (PD). Eleven PD patients were scanned with both [15O]-H2O and [18F]-fluorodeoxyglucose positron emission tomography in the unmedicated state and duri
Autor:
Christine Edwards, Vijay Dhawan, Andrew Feigin, Yilong Ma, Michael G. Kaplitt, David Eidelberg, Kotaro Asanuma, Chengke Tang, Paul J. Mattis
Publikováno v:
Brain. 129:2667-2678
It has been proposed that deep brain stimulation (DBS) of the subthalamic nucleus (STN DBS) and dopaminergic therapy ameliorate the symptoms of Parkinson's disease through similar functional mechanisms. We examined this notion using PET to compare th
Autor:
John C. Rothwell, Yuki Hosono, Nagako Murase, Kazumi Nakamura, Masafumi Harada, Yusuke Morita, Kotaro Asanuma, Sachiko Chikahisa, Hiroyoshi Sei, Hideki Shimazu, Ryo Urushihara, Kazuyoshi Kitaoka, Ryuji Kaji
Publikováno v:
NeuroImage. 31:699-709
Somatosensory-evoked potentials (SEPs) are attenuated by movement. This phenomenon of 'gating' reflects sensorimotor integration for motor control. The frontal N30 component after median nerve stimulation was shown to be reduced in amplitude prior to
Autor:
T. Kawanishi, Kotaro Asanuma, Masutaro Kanda, Hiroshi Shibasaki, Ryuji Kaji, Hidekazu Tomimoto, N. Oka, Masaru Matsui, Ichiro Akiguchi, Tamotsu Kubori, Kotaro Mizutani, Y. Kojima
Publikováno v:
European Neurology. 53:64-67
We analyzed the CD16+CD57– lymphocyte subset, which is considered to have strong natural killer (NK) cell activity, in peripheral blood from patients with chronic immune-mediated neuropathies and patients with other neurological diseases. We found